Healthcare, Pharma & Life Sciences

Eskenazi Joins Faculty of 14th Annual IAFA Aesthetic Symposium

Image
Eskenazi Joins Faculty of 14th Annual IAFA Aesthetic Symposium

Miami Beach, Fla. – September 23, 2026 -- Benjamin Eskenazi MD, FACS, founder of Avabello Aesthetics, has been named to the faculty of the 14th Annual IAFA Aesthetic Symposium, set for the Fontainebleau Miami Beach on November 6-7, 2026.

Dr. Eskenazi will co-instruct a pre-symposium injection masterclass on November 5

The five-hour Anatomy & Injection Masterclass runs from 2:00 to 7:00 p.m. and is led by Professor Sebastian Cotofana, MD, PhD, PhD. The course combines cadaver dissections with live patient injection demonstrations and real-time facial ultrasound, covering neurotoxin treatment of the forehead, glabella and crow's feet, and filler treatment of the temples, tear troughs, cheeks, nasolabial folds, lips, chin and jawline. Dr. Eskenazi will perform live injections alongside co-instructors Terry Alford, DMD; Lanna Cheuck, DO; Barbara Brandt, APRN; Jill Campbell, MSN, FNP-C, CANS; and Shanna Concepcion, RN, CANS.

Mölnlycke Report Finds Hospitals Underuse Day Surgery Capacity

Gothenburg – September 23, 2026 -- Mölnlycke Health Care has released The Hidden Capacity Report, an international study identifying significant untapped capacity in day surgery that could improve surgical throughput and reduce waiting times across healthcare systems.

Survey of 256 healthcare professionals across ten countries exposes adoption gaps

The report draws on a review of international literature, a survey of 256 healthcare professionals across ten countries, expert interviews and guidance from an international expert panel of key opinion leaders. Despite strong clinical evidence supporting day surgery, adoption remains inconsistent across countries, healthcare organisations, specialties and individual clinical teams.

GROWNSY Debuts at NANN Conference, Partners on Nasal Congestion Podcast

Image
GROWNSY Debuts at NANN Conference, Partners on Nasal Congestion Podcast

West Palm Beach – September 23, 2026 -- GROWNSY, a baby care brand serving over 3 million households globally, exhibited for the first time at NANN's 42nd Annual Conference held September 15-18, 2026, in West Palm Beach, Florida, marking its entry into the neonatal clinical channel.

GROWNSY showcases NICU-to-home product line at neonatal nursing conference

The company displayed its SniffEase nasal care line alongside a Compact Bottle Sterilizer and Dryer, Electronic Infant Scale with Height Measurement, Postpartum Recovery Kit, and Perineal Massage and Pelvic Floor Wand, targeting families transitioning from NICU care to home routines.

GROWNSY CEO cites nurse engagement as strategic priority

Yvonne, CEO of GROWNSY, said meeting neonatal nurses who guide families from NICU to home reinforced the company's product development rationale.

Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Image
Exosomes Market to Hit $2.25B by 2034 on 28.8% CAGR

Pune, India – – September 23, 2026 -- The global exosomes market is set to grow nearly tenfold over the next decade, expanding from USD 230.55 million in 2025 to USD 2,250 million by 2034, according to a new analysis from Maximize Market Research. The projected 28.8% compound annual growth rate between 2026 and 2034 places exosome technology among the fastest-expanding segments in biopharmaceutical R&D.

Drug delivery pipelines drive commercial momentum

Pharmaceutical and biotechnology companies are expanding exosome-related pipelines as the nanosized extracellular vesicles gain traction as targeted carriers for drugs, proteins, and RNA. Rising investment in biotechnology and advances in isolation, characterization, and engineering technologies are pushing exosomes beyond research settings into drug development and regenerative medicine applications.

WesternU Hosts Second A.P. Howells Lectureship, Launches New Honors

Image
WesternU Hosts Second A.P. Howells Lectureship, Launches New Honors

Lebanon, Ore. – September 23, 2026 -- Western University of Health Sciences Heatherington College of Osteopathic Medicine (WesternU HCOM) hosted its second annual A.P. Howells, DO, Endowed Lectureship on Aug. 29-30, 2026, training physicians in the Fascial Distortion Model (FDM) for musculoskeletal treatment.

Todd Capistrant, DO, led hands-on FDM training combining online modules with supervised clinical practice

Capistrant, a Medical Director at Foundation Health Partners since 2013 and a board-certified family medicine physician, taught participants to identify fascial distortion patterns and apply introductory osteopathic manipulative treatment techniques. He emphasized that patient activity levels remain a stronger predictor of long-term health outcomes than pharmaceutical interventions for reducing heart disease, stroke, dementia and cancer risk.

OxiWear Signs Exclusive Qatar Distribution Deal with AMNM

Image
OxiWear Signs Exclusive Qatar Distribution Deal with AMNM

Doha – September 23, 2026 -- OxiWear Inc. has signed an exclusive distribution partnership with Alfardan Medical with Northwestern Medicine (AMNM) to bring its wearable physiological measurement technology into Qatar, marking the U.S. company's latest push into the Middle East.

OxiWear taps AMNM's local network to enter Qatar's healthcare technology market

Under the agreement, OxiWear and AMNM will jointly handle distribution, market development, and customer engagement for OxiWear's continuous physiological measurement products across Qatar. AMNM, a multi-specialty day-care surgery center based in Lusail and operated in affiliation with Chicago-based Northwestern Medicine, provides OxiWear with an established clinical network and regional expertise in outpatient care.

Lupus Nephritis Market to Reach $4.08B by 2034, 8.5% CAGR

Image
Lupus Nephritis Market to Reach $4.08B by 2034, 8.5% CAGR

Pune, India – September 23, 2026 -- The global lupus nephritis market was valued at $1.96 billion in 2025 and is projected to reach $4.08 billion by 2034, expanding at a compound annual growth rate of 8.5% through the forecast period, according to a new analysis by Maximize Market Research.

North America leads treatment adoption on strong pharmaceutical research capabilities

North America holds the leading position in the market, supported by advanced healthcare infrastructure and higher awareness of autoimmune diseases. The United States drives regional demand through its established pharmaceutical industry and strong clinical research activity, while Canada contributes through its developed healthcare system focused on autoimmune disease management.

Apollo-Backed Forge to Acquire Becker's Healthcare from Pamlico Capital

Image
Apollo-Backed Forge to Acquire Becker's Healthcare from Pamlico Capital

New York – September 23, 2026 -- Forge, the B2B events and media company backed by Apollo, has agreed to acquire Becker's Healthcare from Pamlico Capital, adding a platform that reaches more than 1.5 million healthcare leaders and executives.

Becker's Healthcare brings a 15,000-attendee live events network to the deal

Chicago-based Becker's Healthcare hosts more than 15,000 attendees annually across its live events, serving hospital, health system and healthcare executives through digital products, executive communities and conferences.

Anonymous Donor Gives $100M to Princess Margaret Cancer Foundation

Image
Anonymous Donor Gives $100M to Princess Margaret Cancer Foundation

Toronto – September 23, 2026 -- The Princess Margaret Cancer Foundation has secured a $100 million gift from an anonymous donor, the largest single donation in the foundation's history and the largest cancer-related gift ever recorded in Canada.

Foundation launches $2.5 billion campaign to fund cancer breakthroughs

The gift anchors the launch of "Carry The Fire," a $2.5 billion fundraising campaign aimed at accelerating cancer research, treatment and care at Princess Margaret Cancer Centre. The donation, tied to the donor's personal experience with cancer, will be directed toward the Centre's highest-priority needs across research, education and patient care, giving administrators flexibility to fund breakthroughs as they emerge.

Aflac Delivers Robotic Ducks to Pediatric Cancer Patients in St. Louis

Image
Aflac Delivers Robotic Ducks to Pediatric Cancer Patients in St. Louis

St. Louis – September 23, 2026 -- Aflac Incorporated brought its My Special Aflac Duck robotic companion to pediatric cancer and sickle cell disease patients at SSM Health Cardinal Glennon Children's Hospital, part of a program that has distributed nearly 50,000 units free of charge since 2018 across the U.S., Japan and Northern Ireland.

Former MLB and NFL player Brian Jordan joined Aflac U.S. President Virgil Miller to read his children's book at the event

Jordan, who played seven Major League Baseball seasons in St. Louis before founding the Brian Jordan Foundation, read his book "I Told You I Can Play" to patients and families, distributing copies alongside the duck deliveries.